Murali C Krishna Selected Research

tempol

1/2022	The antioxidant tempol transforms gut microbiome to resist obesity in female C3H mice fed a high fat diet.
1/2019	Effects of oxygen challenging to tissue redox and pO2 status.
12/2012	The relationship between tissue oxygenation and redox status using magnetic resonance imaging.
11/2012	Targeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.
9/2012	The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.
8/2010	Inhibition of adipogenesis by Tempol in 3T3-L1 cells.
8/2008	Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
8/2007	Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.
10/2006	Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
6/2004	Factors influencing nitroxide reduction and cytotoxicity in vitro.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Murali C Krishna Research Topics

Disease

88	Neoplasms (Cancer) 10/2022 - 01/2002
21	Hypoxia (Hypoxemia) 01/2022 - 02/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018 - 02/2002
5	Adenocarcinoma 01/2022 - 01/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 08/2008
3	Body Weight (Weight, Body) 09/2012 - 10/2009
3	Carcinogenesis 09/2012 - 01/2003
2	Obesity 01/2022 - 08/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2019
2	Glioma (Gliomas) 11/2021 - 01/2021
2	Necrosis 01/2021 - 01/2018
2	Stroke (Strokes) 01/2019 - 06/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 09/2012
2	Kidney Neoplasms (Kidney Cancer) 12/2014 - 11/2012
2	Fibrosarcoma 05/2010 - 01/2002
2	Ischemia 10/2008 - 12/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2008 - 05/2002
1	Weight Gain 01/2022
1	Residual Neoplasm 10/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2019
1	Pathologic Processes 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Lactic Acidosis 12/2016
1	Colonic Neoplasms (Colon Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

34	Oxygen (Dioxygen)IBA 10/2022 - 02/2002
15	Pyruvic Acid (Pyruvate)IBA 01/2021 - 03/2012
14	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 05/2008
11	nitroxylIBA 01/2022 - 05/2002
11	tempolIBA 01/2022 - 01/2003
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2012
9	Contrast MediaIBA 02/2018 - 02/2002
9	carbogenIBA 12/2016 - 02/2002
8	ProdrugsIBA 01/2022 - 09/2005
8	AntioxidantsIBA 01/2022 - 01/2003
6	Pharmaceutical PreparationsIBA 10/2021 - 11/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2006
5	TH 302IBA 10/2021 - 01/2014
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 11/2015
4	EnzymesIBA 10/2019 - 07/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 06/2008
4	Sunitinib (Sutent)FDA Link 09/2014 - 10/2009
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2012
3	pimonidazoleIBA 10/2021 - 04/2007
3	FumaratesIBA 01/2021 - 12/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 12/2016
3	Cytidine Monophosphate (CMP)IBA 01/2019 - 01/2011
3	Oxo63IBA 01/2018 - 02/2002
3	Protons (Proton)IBA 01/2018 - 02/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2014 - 08/2008
3	lithium phthalocyanineIBA 05/2010 - 10/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2010
2	malic acid (malate)IBA 01/2021 - 01/2018
2	Free RadicalsIBA 01/2019 - 08/2007
2	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 12/2018 - 10/2009
2	NitroimidazolesIBA 01/2018 - 04/2007
2	isophosphamide mustard (IPAM)IBA 01/2018 - 01/2014
2	Amifostine (Ethyol)FDA LinkGeneric 01/2018 - 05/2017
2	Angiogenesis InhibitorsIBA 09/2014 - 10/2011
2	Tyrosine Kinase InhibitorsIBA 09/2014 - 10/2011
2	Biological ProductsIBA 10/2013 - 06/2010
2	IronIBA 08/2008 - 07/2002
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2008 - 09/2005
2	Thrombospondin 1IBA 08/2008 - 12/2007
2	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 08/2007 - 09/2004
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2007 - 09/2005
2	Glutathione (Reduced Glutathione)IBA 07/2004 - 01/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2022
1	PEGPH20IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Hyaluronan SynthasesIBA 01/2022
1	Angiopoietin-Like Protein 4IBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 11/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2021
1	alpha-hydroxyglutarateIBA 11/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	EWS-FLI fusion proteinIBA 10/2019
1	Lactate Dehydrogenase 5IBA 10/2019
1	Oxyhemoglobins (Oxyhemoglobin)IBA 12/2018
1	Gadolinium DTPA (Magnevist)FDA Link 12/2018
1	AlginatesIBA 11/2018
1	HydrogelsIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	methyl radicalIBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 12/2016

Therapy/Procedure

22	Therapeutics 01/2022 - 01/2002
21	Radiotherapy 10/2022 - 07/2004
9	Drug Therapy (Chemotherapy) 10/2021 - 05/2008
3	Intravenous Administration 10/2019 - 03/2012
2	Anesthesia 01/2018 - 03/2008
2	Electrodes (Electrode) 02/2004 - 05/2002
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Intravenous Injections 12/2018
1	Intravenous Infusions 01/2018